Clinical trial end points for high-grade glioma: The evolving landscape

David A. Reardon; Evanthia Galanis; John F. DeGroot; Timothy F. Cloughesy; Jeffrey S. Wefel; Kathleen R. Lamborn; Andrew B. Lassman; Mark R. Gilbert; John H. Sampson; Wolfgang Wick; Marc C. Chamberlain; David R. Macdonald; Minesh P. Mehta; Michael A. Vogelbaum; Susan M. Chang; Martin J. Van den Bent; Patrick Y. Wen

doi:10.1093/neuonc/noq203

Clinical trial end points for high-grade glioma: The evolving landscape

David A. Reardon, Evanthia Galanis, John F. DeGroot, Timothy F. Cloughesy, Jeffrey S. Wefel, Kathleen R. Lamborn, Andrew B. Lassman, Mark R. Gilbert, John H. Sampson, Wolfgang Wick, Marc C. Chamberlain, David R. Macdonald, Minesh P. Mehta, Michael A. Vogelbaum, Susan M. Chang, Martin J. Van den Bent, Patrick Y. Wen

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	13
DOIs	https://doi.org/10.1093/neuonc/noq203
State	Published - Mar 1 2011

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.1093/neuonc/noq203License: Unspecified

Cite this

Reardon, D. A., Galanis, E., DeGroot, J. F., Cloughesy, T. F., Wefel, J. S., Lamborn, K. R., Lassman, A. B., Gilbert, M. R., Sampson, J. H., Wick, W., Chamberlain, M. C., Macdonald, D. R., Mehta, M. P., Vogelbaum, M. A., Chang, S. M., Van den Bent, M. J., & Wen, P. Y. (2011). Clinical trial end points for high-grade glioma: The evolving landscape. Neuro-oncology, 13. https://doi.org/10.1093/neuonc/noq203

@article{434f601c55184e3981ef42b0dce51a67,

title = "Clinical trial end points for high-grade glioma: The evolving landscape",

author = "Reardon, \{David A.\} and Evanthia Galanis and DeGroot, \{John F.\} and Cloughesy, \{Timothy F.\} and Wefel, \{Jeffrey S.\} and Lamborn, \{Kathleen R.\} and Lassman, \{Andrew B.\} and Gilbert, \{Mark R.\} and Sampson, \{John H.\} and Wolfgang Wick and Chamberlain, \{Marc C.\} and Macdonald, \{David R.\} and Mehta, \{Minesh P.\} and Vogelbaum, \{Michael A.\} and Chang, \{Susan M.\} and \{Van den Bent\}, \{Martin J.\} and Wen, \{Patrick Y.\}",

year = "2011",

month = mar,

day = "1",

doi = "10.1093/neuonc/noq203",

language = "American English",

volume = "13",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Clinical trial end points for high-grade glioma: The evolving landscape

AU - Reardon, David A.

AU - Galanis, Evanthia

AU - DeGroot, John F.

AU - Cloughesy, Timothy F.

AU - Wefel, Jeffrey S.

AU - Lamborn, Kathleen R.

AU - Lassman, Andrew B.

AU - Gilbert, Mark R.

AU - Sampson, John H.

AU - Wick, Wolfgang

AU - Chamberlain, Marc C.

AU - Macdonald, David R.

AU - Mehta, Minesh P.

AU - Vogelbaum, Michael A.

AU - Chang, Susan M.

AU - Van den Bent, Martin J.

AU - Wen, Patrick Y.

PY - 2011/3/1

Y1 - 2011/3/1

UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064608/

U2 - 10.1093/neuonc/noq203

DO - 10.1093/neuonc/noq203

M3 - Article

VL - 13

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Clinical trial end points for high-grade glioma: The evolving landscape

Disciplines

Access to Document

Other files and links

Cite this